IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 167 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,201,213 | -57.0% | 436,263 | -52.5% | 0.00% | -60.0% |
| Q2 2023 | $9,778,138 | +16.1% | 918,998 | +14.8% | 0.01% | +11.1% |
| Q1 2023 | $8,423,606 | +8.4% | 800,723 | +27.6% | 0.01% | 0.0% |
| Q4 2022 | $7,773,313 | +34.6% | 627,386 | +12.5% | 0.01% | +28.6% |
| Q3 2022 | $5,775,000 | -33.3% | 557,434 | -25.8% | 0.01% | -30.0% |
| Q2 2022 | $8,664,000 | -41.9% | 751,429 | -36.7% | 0.01% | -28.6% |
| Q1 2022 | $14,925,000 | +44.8% | 1,186,382 | +34.2% | 0.01% | +55.6% |
| Q4 2021 | $10,308,000 | -40.5% | 884,094 | -33.3% | 0.01% | -43.8% |
| Q3 2021 | $17,310,000 | +36.7% | 1,325,427 | +34.7% | 0.02% | +45.5% |
| Q2 2021 | $12,667,000 | -25.5% | 984,238 | -35.3% | 0.01% | -31.2% |
| Q1 2021 | $17,005,000 | -30.2% | 1,521,040 | -28.9% | 0.02% | -27.3% |
| Q4 2020 | $24,366,000 | +46.6% | 2,139,227 | +15.7% | 0.02% | +29.4% |
| Q3 2020 | $16,626,000 | -6.0% | 1,848,305 | +7.8% | 0.02% | -19.0% |
| Q2 2020 | $17,690,000 | +5.1% | 1,714,187 | +2.7% | 0.02% | -19.2% |
| Q1 2020 | $16,838,000 | -13.7% | 1,668,789 | +13.9% | 0.03% | +18.2% |
| Q4 2019 | $19,508,000 | +240.0% | 1,465,626 | +119.3% | 0.02% | +214.3% |
| Q3 2019 | $5,737,000 | -17.7% | 668,296 | +4.9% | 0.01% | -22.2% |
| Q2 2019 | $6,972,000 | -47.8% | 637,354 | -35.5% | 0.01% | -47.1% |
| Q1 2019 | $13,361,000 | +79.3% | 987,532 | +37.3% | 0.02% | +70.0% |
| Q4 2018 | $7,453,000 | +68.2% | 719,442 | +199.8% | 0.01% | +100.0% |
| Q3 2018 | $4,430,000 | +101.8% | 239,980 | +109.0% | 0.01% | +66.7% |
| Q2 2018 | $2,195,000 | -17.5% | 114,809 | -33.4% | 0.00% | -25.0% |
| Q1 2018 | $2,660,000 | -44.1% | 172,370 | -45.7% | 0.00% | -42.9% |
| Q4 2017 | $4,761,000 | +3.4% | 317,601 | +8.8% | 0.01% | 0.0% |
| Q3 2017 | $4,603,000 | -4.4% | 291,857 | +14.5% | 0.01% | -12.5% |
| Q2 2017 | $4,814,000 | -46.2% | 254,985 | -51.4% | 0.01% | -50.0% |
| Q1 2017 | $8,950,000 | -7.1% | 524,594 | -16.7% | 0.02% | 0.0% |
| Q4 2016 | $9,633,000 | +16.9% | 629,994 | +21.4% | 0.02% | +6.7% |
| Q3 2016 | $8,242,000 | +113.4% | 519,023 | +75.7% | 0.02% | +114.3% |
| Q2 2016 | $3,863,000 | +9.3% | 295,455 | -8.5% | 0.01% | +16.7% |
| Q1 2016 | $3,534,000 | +5.0% | 323,002 | +11.3% | 0.01% | +20.0% |
| Q4 2015 | $3,365,000 | +77.1% | 290,331 | +59.2% | 0.01% | +66.7% |
| Q3 2015 | $1,900,000 | -73.3% | 182,388 | -69.0% | 0.00% | -72.7% |
| Q2 2015 | $7,105,000 | -49.2% | 589,108 | -32.7% | 0.01% | -47.6% |
| Q1 2015 | $13,999,000 | +26.9% | 874,918 | +21.5% | 0.02% | +50.0% |
| Q4 2014 | $11,034,000 | +59.2% | 720,231 | +34.6% | 0.01% | +55.6% |
| Q3 2014 | $6,933,000 | +265.7% | 535,196 | +332.8% | 0.01% | +200.0% |
| Q2 2014 | $1,896,000 | +220.8% | 123,647 | +157.8% | 0.00% | +200.0% |
| Q1 2014 | $591,000 | -0.2% | 47,955 | -6.0% | 0.00% | 0.0% |
| Q4 2013 | $592,000 | -31.8% | 51,018 | -30.3% | 0.00% | 0.0% |
| Q3 2013 | $868,000 | -39.5% | 73,242 | -49.2% | 0.00% | -66.7% |
| Q2 2013 | $1,435,000 | – | 144,215 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |